1. Home
  2. GGR vs CLNN Comparison

GGR vs CLNN Comparison

Compare GGR & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogoro Inc.

GGR

Gogoro Inc.

HOLD

Current Price

$4.35

Market Cap

82.9M

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$6.08

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGR
CLNN
Founded
2011
2012
Country
Taiwan
United States
Employees
1416
79
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.9M
73.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GGR
CLNN
Price
$4.35
$6.08
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$33.00
AVG Volume (30 Days)
5.9K
80.0K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.07
$17.64
Revenue Next Year
N/A
$19,516.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$2.28
52 Week High
$6.21
$13.50

Technical Indicators

Market Signals
Indicator
GGR
CLNN
Relative Strength Index (RSI) 65.32 55.89
Support Level $3.63 $5.59
Resistance Level $4.25 $6.83
Average True Range (ATR) 0.21 0.53
MACD 0.03 0.04
Stochastic Oscillator 81.17 74.47

Price Performance

Historical Comparison
GGR
CLNN

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: